Iridex Corp (IRIX) is a publicly traded Healthcare sector company. As of May 20, 2026, IRIX trades at $1.07 with a market cap of $17.66M and a P/E ratio of 0.00. IRIX moved +3.45% today. Year to date, IRIX is -10.26%; over the trailing twelve months it is -1.87%. Its 52-week range spans $0.78 to $1.95. Analyst consensus is buy with an average price target of $2.75. Rallies surfaces IRIX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading IRIX stock inside the company?
Recent IRIX insider activity includes Dizon Romeo R bought 1.11K, Dizon Romeo R bought 1.00K, Dizon Romeo R bought 1.20K, Dizon Romeo R bought 1.50K, and Dizon Romeo R bought 1.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
IRIX Key Metrics
Key financial metrics for IRIX
Metric
Value
Price
$1.07
Market Cap
$17.66M
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$1.95
52-Week Low
$0.78
Volume
127.58K
Avg Volume
0
Revenue (TTM)
$0
Net Income
$0
Gross Margin
0.00%
Recent IRIX Insider Trades
Dizon Romeo R bought 1.11K (~$1.40K) on Mar 6, 2026.
Dizon Romeo R bought 1.00K (~$1.37K) on Feb 17, 2026.
Dizon Romeo R bought 1.20K (~$1.57K) on Feb 17, 2026.
Dizon Romeo R bought 1.50K (~$2.15K) on Feb 12, 2026.
Dizon Romeo R bought 1.00K (~$1.46K) on Feb 10, 2026.
Recent IRIX insider activity includes Dizon Romeo R bought 1.11K, Dizon Romeo R bought 1.00K, Dizon Romeo R bought 1.20K, Dizon Romeo R bought 1.50K, and Dizon Romeo R bought 1.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for IRIX?
Yes. Rallies tracks IRIX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is IRIX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IRIX. It does not provide personalized investment advice.
